Abstract
The abilities of 4 antimalaria drugs (Daraprim, Fansidar, Nivaquine and Camoquine) on their own and in combination with aflatoxin B1 to induce prophage in tester strains E. coli D21 and D22 were studied. The 4 drugs were found to induce prophage in the tester strains; Daraprim and Fansidar without the need for activation by liver mixed function oxidases (S9 microsomal fraction), while Nivaquine and Camoquine did require activation by this system. Aflatoxin B1 was used as a positive control in all the tests. The combined effects of each of the drugs with aflatoxin B1 were lower than that of the individual drugs acting alone. From these results, it may be concluded that the drugs may, on their own, pose a carcinogenic hazard to the population in the Nigerian environment exposed to them. In addition, the depression of prophage induction observed when the drugs were combined with aflatoxin B1 may be indicative of a common target site of action in the tester strains.
References
Jan 1, 1978·World Review of Nutrition and Dietetics·E A BababunmiO Bassir
Nov 1, 1979·Cancer Letters·A O UwaifoE A Bababunmi
Oct 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·P MoreauR Devoret
Mar 1, 1975·Annals of Tropical Medicine and Parasitology·A N Lewis, J T Ponnampalam
Apr 16, 1975·Biochimica Et Biophysica Acta·A B Stone, D Wilkie
Dec 1, 1975·British Journal of Cancer·M C ZumelM D Astudillo
Jan 1, 1974·Advances in Parasitology·W Peters
Sep 1, 1971·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·C KidoM Kaneko
Dec 1, 1974·Mutation Research·R O Michael, G M Williams
May 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·P K Cooper, P C Hanawalt
Nov 1, 1972·Journal of Medicinal Chemistry·J B Hynes, L G Hack
Nov 1, 1973·The Journal of Infectious Diseases·J J Burchall
May 17, 1974·Biochimica Et Biophysica Acta·T J SimonP C Hanawalt
Feb 15, 1973·Biochemical Pharmacology·M E WashingtonD J Holbrook
Nov 1, 1973·The Journal of Infectious Diseases·G H Hitchings
Jan 21, 1966·Science·J Ciak, F E Hahn
Jun 1, 1971·Biochemical Pharmacology·C H Lantz, K Van Dyke
Aug 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·S N Cohen, K L Yielding
Jan 1, 1983·The Japanese Journal of Surgery·T KanematsuK Inokuchi
Apr 1, 1980·Mutation Research·A S SideropoulosM T Jones
Jul 1, 1980·Mutation Research·A S Raj, J A Heddle
Nov 2, 1963·Nature·H MARCOVICH, H S KAPLAN
Jun 1, 1955·British Journal of Pharmacology and Chemotherapy·I M ROLLO
Citations
Feb 19, 2000·Teratogenesis, Carcinogenesis, and Mutagenesis·K K Vijayalaxmi, M Vishalakshi
Feb 3, 2005·Cell Biology and Toxicology·A Abou-Eisha, M Afifi
Mar 10, 1998·Journal of Photochemistry and Photobiology. B, Biology·J D Spikes
Aug 14, 1997·Mutation Research·Y F SasakiS Tsuda
Aug 26, 1998·Mutation Research·S TsudaY F Sasaki
Apr 1, 1994·Mutation Research·T OnoH Yoshimura